Principal Financial Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-99,106
| Closed | -$406K | – | 2717 |
|
|
2022
Q1 | $406K | Sell |
99,106
-32,454
| -25% | -$118K | ﹤0.01% | 2170 |
|
|
2021
Q4 | $469K | Buy |
131,560
+96,553
| +276% | +$338K | ﹤0.01% | 2142 |
|
|
2021
Q3 | $127K | Buy |
35,007
+8,317
| +31% | +$33.6K | ﹤0.01% | 2479 |
|
|
2021
Q2 | $116K | Sell |
26,690
-9,246
| -26% | -$37.7K | ﹤0.01% | 2519 |
|
|
2021
Q1 | $148K | Sell |
35,936
-5,678
| -14% | -$24.6K | ﹤0.01% | 2400 |
|
|
2020
Q4 | $166K | Sell |
41,614
-17,312
| -29% | -$56K | ﹤0.01% | 2323 |
|
|
2020
Q3 | $159K | Sell |
58,926
-3,072
| -5% | -$8.5K | ﹤0.01% | 2234 |
|
|
2020
Q2 | $171K | Buy |
61,998
+38,607
| +165% | +$108K | ﹤0.01% | 2207 |
|
|
2020
Q1 | $55K | Buy |
23,391
+102
| +0.4% | +$347 | ﹤0.01% | 2148 |
|
|
2019
Q4 | $109K | Sell |
23,289
-45,122
| -66% | -$185K | ﹤0.01% | 2184 |
|
|
2019
Q3 | $229K | Buy |
68,411
+7,702
| +13% | +$25.4K | ﹤0.01% | 2110 |
|
|
2019
Q2 | $200K | Sell |
60,709
-1,892
| -3% | -$5.47K | ﹤0.01% | 2148 |
|
|
2019
Q1 | $189K | Sell |
62,601
-339
| -0.5% | -$1.1K | ﹤0.01% | 2123 |
|
|
2018
Q4 | $171K | Sell |
62,940
-3,235
| -5% | -$10.7K | ﹤0.01% | 2152 |
|
|
2018
Q3 | $223K | Buy |
66,175
+6,859
| +12% | +$21.2K | ﹤0.01% | 2144 |
|
|
2018
Q2 | $153K | Sell |
59,316
-18,788
| -24% | -$46.8K | ﹤0.01% | 2191 |
|
|
2018
Q1 | $172K | Buy |
78,104
+1,454
| +2% | +$3.27K | ﹤0.01% | 2120 |
|
|
2017
Q4 | $152K | Buy |
76,650
+51,866
| +209% | +$113K | ﹤0.01% | 2161 |
|
|
2017
Q3 | $80K | Sell |
24,784
-1,514
| -6% | -$4.67K | ﹤0.01% | 2149 |
|
|
2017
Q2 | $85K | Buy |
+26,298
| New | +$74.5K | ﹤0.01% | 2200 |
|
|
2016
Q2 | – | Sell |
-34,386
| Closed | -$30K | – | 2222 |
|
|
2016
Q1 | $30K | Buy |
34,386
+3,179
| +10% | +$3.08K | ﹤0.01% | 2144 |
|
|
2015
Q4 | $38K | Buy |
31,207
+2,237
| +8% | +$3.11K | ﹤0.01% | 2166 |
|
|
2015
Q3 | $49K | Sell |
28,970
-13,684
| -32% | -$26.8K | ﹤0.01% | 2142 |
|
|
2015
Q2 | $89K | Buy |
42,654
+8,213
| +24% | +$19.9K | ﹤0.01% | 2142 |
|
|
2015
Q1 | $93K | Buy |
+34,441
| New | +$87.4K | ﹤0.01% | 2109 |
|
|
2014
Q3 | – | Sell |
-38,142
| Closed | -$102K | – | 2254 |
|
|
2014
Q2 | $102K | Sell |
38,142
-18,989
| -33% | -$57.2K | ﹤0.01% | 2199 |
|
|
2014
Q1 | $200K | Buy |
+57,131
| New | +$253K | ﹤0.01% | 2134 |
|
|
2013
Q4 | – | Sell |
-54,318
| Closed | -$221K | – | 2320 |
|
|
2013
Q3 | $221K | Buy |
+54,318
| New | +$237K | ﹤0.01% | 2081 |
|
Other funds holding ATRS
Principal Financial Group's ATRS Position: Q2 2022 in Review
Principal Financial Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 99,106 shares — an estimated $406K sold.
Principal Financial Group first reported a position in ATRS in Q3 2013 and held it in 28 quarters. The position peaked at $469K in Q4 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Principal Financial Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Principal Financial Group sold 99,106 Antares Pharma, Inc. shares in Q2 2022, an estimated $406K.
- Principal Financial Group first reported a position in Antares Pharma, Inc. in Q3 2013 and held it in 28 quarters.
- Principal Financial Group's Antares Pharma, Inc. position peaked at $469K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.